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LETTERS

Letters to the Editor
Trichotillomania and Bipolar Disorder
TO THE EDITOR: We read with interest the article by Grant and

Chamberlain (1), published in the September 2016 issue of the
Journal, on the assessment and treatment of trichotillomania.
As the authors point out, psychiatric comorbidity is the rule
rather than the exception in patients with trichotillomania.
In one study (2), approximately 55% of patients with trichotillomania met DSM-III-R criteria for a lifetime diagnosis of
a mood disorder, including bipolar disorder in a small number
of patients. While major depressive disorder is the most
common mood disorder, the relationship between trichotillomania and bipolar disorder remains unclear (3).
Over the past few years, we have successfully treated
several women at our perinatal psychiatric clinic who were
comorbid for bipolar II disorder and trichotillomania (4).
Interestingly, all of our patients (N55) had experienced
exacerbation of symptoms of trichotillomania immediately
after giving birth. All patients failed to respond to trials of
selective serotonin reuptake inhibitors (SSRIs), and two
patients failed to respond to olanzapine. However, there was
a robust and sustained response to lithium (in three patients)
or lamotrigine (in two patients) monotherapy.
Studies have shown a correlation between changes in
reproductive physiology and the onset or exacerbation of
symptoms of trichotillomania in humans and hair plucking
behavior (barbering) in mice (S. Husk, 2010 master’s thesis).
Childbirth is also a well-recognized trigger of onset or exacerbation of bipolar disorder.
As the authors point out, SSRIs are not generally effective
in trichotillomania. Moreover, the use of these drugs in patients
with bipolar disorder may lead to further mood instability.
Available literature, although limited to anecdotal reports,
suggests that antidepressants should be avoided in favor of
mood stabilizers for management of trichotillomania and bipolar disorder comorbidity.
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Reﬁning Treatment Approaches in Comorbid
Trichotillomania and Bipolar Disorder:
Response to Sharma and Baczynski
TO THE EDITOR: Sharma and Baczynski present ﬁve cases
of co-occurring trichotillomania and bipolar disorder with
worsening of trichotillomania symptoms following childbirth.
The individuals in question responded to either lithium or
lamotrigine. This case series of the comorbidity of trichotillomania and bipolar disorder, as well as the exacerbation of
hair pulling postchildbirth, raises important clinical and research issues: the role of sex hormones in the pathophysiology
of trichotillomania, and appropriate pharmacological management of these disorders when they co-occur. The authors
mention a correlation between changes in reproductive
physiology and hair plucking behavior in mice. In furtherance
of the possible role of sex hormones in trichotillomania, a recent
study showed that 94% of a large sample of patients who sought
treatment for trichotillomania (N5462) were female and that
the majority reported an age of onset coincident with puberty
(12 years of age) (1). Taken together, these ﬁndings seemingly
beg for an examination of sex hormones in trichotillomania. In
terms of pharmacological treatment of this comorbidity, this
case series supports the possible use of lithium and lamotrigine.
Both lithium and anticonvulsants have been reported as potentially beneﬁcial for trichotillomania, even in the absence of
bipolar disorder, in case reports or open-label studies (2–4).
Despite promising research, there is no clear ﬁrst-line pharmacological agent for trichotillomania. Previous research has
suggested that understanding the heterogeneity of the disorder
(i.e., using clinical, neurocognitive, and neuroimaging ﬁndings
to subtype people with the disorder) may improve treatment
approaches (5). This case series importantly adds to this approach by suggesting that comorbidity and timing of symptom
exacerbation may further reﬁne treatment approaches.
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